Performance characteristics of the ARCHITECT® Anti-HCV assay

Journal of Clinical Virology

Volumn 34, Issue 2, 2005, Pages 97-103

  Jonas, Gesa ^a   Pelzer, Claudia ^a   Beckert, Christian ^a   Hausmann, Michael ^a   Kapprell, Hans Peter ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Anti HCV; Hepatitis C; Immunoassay; Performance evaluation; Specificity

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GERMANY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL; SEROCONVERSION;

AUTOMATION; BLOOD DONORS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 24644457690     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.08.001     Document Type: Article

References (25)

1. H. Alter Discovery of non-A, non-B hepatitis and identification of its etiology Am J Med 107 Suppl. 6B 1999 16 20
2. M.J. Alter, W.L. Kuhnert, and L. Finelli Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus Morb Mortal Wkly Rep 52 RR-3 2003 1 16
3. M. Bendinelli, M. Pistello, F. Maggi, and M. Vatteroni Blood-borne hepatitis viruses: hepatitis B, C, D, and G viruses and TT virus. S Specter R.L. Hodinka S.A. Young Clinical virology manual 3rd ed. 2000 ASM Press Washington, DC 306 337
4. G.E.P. Box, W.G. Hunter, and J.S. Hunter An introduction to design, data analysis and model building Statistics for Experiments 510-539 1978 Wiley J and Sons Inc. 571 583
5. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
6. R.Y. Dodd Current viral risks of blood and blood products Ann Med 32 2000 469 474
7. J.G. Donahue, A. MuUoz, and P.M. Ness The declining risk of post-transfusion hepatitis C virus infection N Engl J Med 327 1992 369 373
8. N.F. Hallam, M.L. Fletcher, S.J. Read, A.M. Majid, J.B. Kurtz, and C.R. Rizza Low risk of sexual transmission of hepatitis C virus J Med Virol 40 1993 251 253
9. K.A. Janatpour, M. Kemper, S. Aceituno, and P. Holland Incidence of mini-pool HCV NAT negative, single unit NAT positive units among serological positive blood donations Transfusion 42 Suppl. 2002 80S
10. Japanese Red Cross Non-A, Non-B Hepatitis Research Group Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis Lancet 338 1991 1040 1041
11. P. Kiely, D. Kay, S. Parker, and L. Piscitell The significance of third-generation HCV RIBA-indeterminate RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassay Transfusion 44 2004 349 358
12. S.H. Kleinman, A.E. Williams, M.P. Busch, and Y. Wu Donor reactions to notification of abnormal test results Transfusion 39 Suppl. 1999 113 [abstract]
13. I.K. Kuramoto, T. Moriya, V. Schoening, and P.V. Holland Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection J Virol Hepatitis 9 2002 36 42
14. G.M. Lauer,. Walker, and B.D. Hepatitis C virus infection N Engl J Med 345 2001 41 52
15. A.M. Majid, and D.R. Gretch Current and future hepatitis C virus diagnostic testing: problems and advancements Microbes Infect 4 12 2002 1227 1236
16. J.M. Pawlotsky Use and interpretation of virological tests for hepatitis C Hepatology 36 2002 65 S73
17. S.J. Polyak, and D.R. Gretch Molecular diagnostic testing for viral hepatitis: methods and applications R.A. Willson Viral hepatitis: diagnosis, treatment, and prevention 4 1997 Marcel Dekker, Inc. New York, NY 1 33
18. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832
19. S.S. Richter Laboratory assays for diagnosis and management of hepatitis C virus infection J Clin Microbiol 41 2003 530 534
20. ® Software changes and enhancements, release 6.07. Cary, NC: SAS Institute Inc.; 1992. p. 289-366.
21. U.K. Sharma, S.L. Stramer, and D.J. Wright Impact of changes in viral marker screening assays Transfusion 43 2003 202 214
22. L.H. Tobler, J. McAuley, and J.P. Brodsky Frequency and significance of very low viremia in minipool NAT negative HCV antibody confirmed positive donors Transfusion 42 Suppl. 2002 3 [abstract]
23. M.J. Tong, N.S. el-Farra, and A.R. Reikes Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
24. A. Wasley, and M.J. Alter Epidemiology of hepatitis C: geographic differences and temporal trends Semin Liver Dis 20 2000 1 16
25. Y. Wu, G.B. Schreiber, and M.P. Busch Donor behavior after notification of abnormal laboratory test results Transfusion 39 Suppl. 1999 113S [abstract]